Search research articles
Contact Us
Filters
Showing results (1121-1130 of 1,482) with videos related to
Page
of 149
Sort By:
The Lancet. Haematology
|
June 27, 2020
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial
Elias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, et al.
American Journal of Hematology
|
December 2, 2020
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality
Abhishek Maiti, Wei Qiao, Koji Sasaki, et al.
The Lancet. Haematology
|
December 28, 2019
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study
Kasiani C Myers, Elissa Furutani, Edie Weller, et al.
Blood Cancer Discovery
|
July 3, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, et al.
Frontiers in Immunology
|
October 5, 2020
Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease
Karina Tozatto-Maio, Robert Girot, Indou Deme Ly, et al.
Cancer
|
April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study
Ajay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Blood Advances
|
July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms
Oriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.
Blood Advances
|
October 25, 2019
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Xi Luo, Simone Feurstein, Shruthi Mohan, et al.
Blood Advances
|
April 1, 2021
Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia
Abhishek Maiti, Courtney D DiNardo, Sa A Wang, et al.
Blood Advances
|
July 11, 2025
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Sanam Loghavi, Ziyi Li, et al.
Page
of 149
Search research articles
Search
Showing results (1121-1130 of 1,482) with videos related to
Sort By:
Page
of 149
The Lancet. Haematology
|
June 27, 2020
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial
Elias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, et al.
American Journal of Hematology
|
December 2, 2020
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality
Abhishek Maiti, Wei Qiao, Koji Sasaki, et al.
The Lancet. Haematology
|
December 28, 2019
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study
Kasiani C Myers, Elissa Furutani, Edie Weller, et al.
Blood Cancer Discovery
|
July 3, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, et al.
Frontiers in Immunology
|
October 5, 2020
Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease
Karina Tozatto-Maio, Robert Girot, Indou Deme Ly, et al.
Cancer
|
April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study
Ajay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Blood Advances
|
July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms
Oriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.
Blood Advances
|
October 25, 2019
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Xi Luo, Simone Feurstein, Shruthi Mohan, et al.
Blood Advances
|
April 1, 2021
Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia
Abhishek Maiti, Courtney D DiNardo, Sa A Wang, et al.
Blood Advances
|
July 11, 2025
Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Sanam Loghavi, Ziyi Li, et al.
Page
of 149